Black Rock Inc. Neuronetics, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Neuronetics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 380,544 shares of STIM stock, worth $658,341. This represents 0.0% of its overall portfolio holdings.

Number of Shares

380,544

Previous 380,129 0.11%

Holding current value

$658,341

Previous $1.1 Million 64.34%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$2.68 - $4.8 $1,112 - $1,992	415 Added 0.11%	380,544 $1.81 Million
Q4 2023 Feb 13, 2024	SELL	$1.05 - $2.9 $825 - $2,279	-786 Reduced 0.21%	380,129 $1.1 Million
Q3 2023 Nov 13, 2023	SELL	$1.29 - $2.22 $3,637 - $6,260	-2,820 Reduced 0.73%	380,915 $514,000
Q2 2023 Aug 11, 2023	BUY	$2.07 - $2.92 $10,592 - $14,941	5,117 Added 1.35%	383,735 $825,000
Q1 2023 May 12, 2023	SELL	$2.81 - $6.71 $114,223 - $272,754	-40,649 Reduced 9.7%	378,618 $1.1 Million

Q4 2022 Feb 13, 2023	BUY	$3.44 - $6.87 $10,182 - $20,335	2,960 Added 0.71%	419,267 $2.88 Million
Q3 2022 Nov 14, 2022	SELL	$2.35 - $4.66 $10,008 - $19,846	-4,259 Reduced 1.01%	416,307 $1.32 Million
Q2 2022 Aug 12, 2022	SELL	$2.09 - $3.71 $2.41 Million - $4.29 Million	-1,155,216 Reduced 73.31%	420,566 $1.35 Million
Q1 2022 May 12, 2022	SELL	$2.84 - $4.52 $53,082 - $84,483	-18,691 Reduced 1.17%	1,575,782 $4.77 Million
Q4 2021 Feb 10, 2022	BUY	$3.87 - $6.59 $88,131 - $150,074	22,773 Added 1.45%	1,594,473 $7.11 Million
Q3 2021 Nov 09, 2021	BUY	$6.22 - $15.54 $284,397 - $710,535	45,723 Added 3.0%	1,571,700 $10.3 Million
Q2 2021 Aug 11, 2021	BUY	$10.15 - $17.25 $15.5 Million - $26.3 Million	1,525,977 New	1,525,977 $24.4 Million

Others Institutions Holding STIM

# of Institutions

Shares Held

18.4M

Call Options Held

200

Put Options Held

3.6K

View Full List

About Neuronetics, Inc.

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $46.7M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

More about STIM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account